I pulled this from the Nano website. It appears that another paper is in the pipeline, and I'm sure there will be more. This is interesting because it shows antibiotic resistance, in this case, to clindamycin. Docs will be able to administer the proper antibiotic ASAP thereby being more efficient and effective....very interesting.
August 12, 2011: Additional Results Submitted for Publication
The paper’s objective is to outline work done to determine if a new method of rapidly detection of Group B Step in 4-6 hours detailed in an earlier paper [link] could also determine antibiotic sensitivities in a shorter period compared to standard cultures.
Testing patient samples with the NanoLogix technology, about a quarter tested positive for GBS in six hours. Of these positive samples, the NanoLogix test also indicated a fraction were resistant to clindamycin (a common antibiotic). These results were in complete agreement with findings of the traditional culture test control of 48-72 hours. Results of the both the rapid and traditional culture showed 100% agreement with sensitivity, or resistance to clindamycin.
This new test from NanoLogix offers a rapid and unique method for both detection and determination of antibiotic sensitivities for Group B Strep; setting the stage for improvement in the administration of antibiotics to combat Group B Strep infection.
Market Data 
Markets 
AI
